Comprehensive characterization of long QT syndrome‐associated genes in cancer and development of a robust prognosis model
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Jincheng Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology (National Key Laboratory of Frigid Zone Cardiovascular Diseases, the State-Province Key Laboratories of Biomedicine-Pharma…. Hauptthemen laut MEDLINE: Long QT Syndrome, Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Heilongjiang Postdoctoral Foundation, Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
Cancer is the leading public health problem worldwide. However, the side effects accompanying anti‐cancer therapies, particularly those pertaining to cardiotoxicity and adverse cardiac events, have been the hindrances to treatment progress. Long QT syndrome (LQTS) is one of the major clinic manifestations of the anti‐cancer drug associated cardiac dysfunction. Therefore, elucidating the relationship between the LQTS and cancer is urgently needed. Transcriptomic sequencing data and clinic information of 10,531 patients diagnosed with 33 types of cancer was acquired from TCGA database. A pan‐cancer applicative gene prognostic model was constructed based on the LQTS gene signatures. Meanwhile, transcriptome data and clinical information from various cancer types were collected from the GEO database to validate the robustness of the prognostic model. Furthermore, the expression level of transcriptomes and multiple clinical features were integrated to construct a Nomo chart to optimize the prognosis model. The ssGSEA analysis was employed to analysis the correlation between the LQTS gene signatures, clinic features and cancer associated signalling pathways. Our findings revealed that patients with lower LQTS gene signatures enrichment levels exhibit a poorer prognosis. The correlation of enrichment levels with the typical pathways was observed in multiple cancers. Then, based on the 17 LQTS gene signatures, we construct a prognostic model through the machine‐learning approaches. The results obtained from the validation datasets and training datasets indicated that our prognostic model can effectively predict patient outcomes across diverse cancer types. Finally, we integrated this model with clinical features into a nomogram, demonstrating its potential as a valuable prognostic tool for cancer patients. Our study sheds light on the intricate relationship between LQTS and cancer pathways. A LQTS feature based clinic decision tool was developed aiming to enhance precision treatment of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology (National Key Laboratory of Frigid Zone Cardiovascular Diseases, the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry…
- Cardiology Department, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
- Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
ORCID-Profile: Yanan Jiang
Förderung
- National Natural Science Foundation of China
- The Heilongjiang Postdoctoral Foundation
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Xu, J., Wen, Z., She, Y., Li, M., Shen, X., Zhi, F., Wang, S., & Jiang, Y. (2024). Comprehensive characterization of long QT syndrome‐associated genes in cancer and development of a robust prognosis model. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70094
Vancouver
Xu J, Wen Z, She Y, Li M, Shen X, Zhi F, et al. Comprehensive characterization of long QT syndrome‐associated genes in cancer and development of a robust prognosis model. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70094
BibTeX
@article{Xu2024,
author = {Xu, Jincheng and Wen, Zhengchao and She, Yongtao and Li, Maohao and Shen, Xiuyun and Zhi, Fengnan and Wang, Shu and Jiang, Yanan},
title = {Comprehensive characterization of long QT syndrome‐associated genes in cancer and development of a robust prognosis model},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70094}
}
EUVIMED